Reticulocyte Hemoglobin Content as the Best Indicator of Iron Deficiency in Female Patients with Diffuse Non-Scarring Hair Loss

    September 2021 in “ Biomedical & Pharmacology Journal ”
    Zahraa Jasim, Hayder Aledan
    Studysummary This study found that the reticulocyte hemoglobin content (CHr) most frequently indicated iron deficiency in female patients with diffuse non-scarring hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on biomedpharmajournal.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. UK Guidelines on the Management of Iron Deficiency in Pregnancy British journal of haematology · 2019
    2. Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use Dermatology practical & conceptual · 2017
    3. The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss Journal of The American Academy of Dermatology · 2006

    Related research 1

    1. Commentary: Iron Deficiency and Hair Loss Journal of the American Academy of Dermatology · 2010